Raina Kaji, MD

Dr. Cheng-Ying Ho is an Associate Professor of Pathology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include neuromuscular pathology, pediatric neuropathology, and neuropathology of infectious diseases. Dr. Ho serves as the Deputy Director for the Neuropathology Fellowship Program.Dr. Ho received her medical degree from National Taiwan University and her Ph.D. in Pathobiology from Columbia University. She completed Anatomic Pathology and Neuropathology combined residency and fellowship training at the Johns Hopkins Hospital. Dr. Ho joined the faculty at Johns Hopkins University School of Medicine in 2022. Dr. Ho’s research interests include the pathogenesis and treatment of sensory neuropathy, with a focus on the impact of the skin microenvironment on the development of diabetic neuropathy. Her laboratory uses diverse approaches to study the role of skin-derived signaling molecules in the maintenance of the cutaneous sensory nerve fibers. Her research also involves development of novel therapeutics for diabetic neuropathy.

Dr. Buddy G. Kozen Jr. is an instructor of emergency medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is emergency medicine. He earned his M.D. at Johns Hopkins and completed an emergency medicine residency at Naval Medical Center.

Dr. Nethra Kumar Madurai is a Clinical Associate in the Division of Neonatology, Department of Pediatrics, Johns Hopkins School of Medicine. She first came to Johns Hopkins as a Pediatric resident in the Harriet Lane Pediatric Residency Program in 2016. She then completed fellowship in Neonatal-Perinatal Medicine at Johns Hopkins Hospital and received the NIH T32 grant as a research fellow during the final year of her fellowship. Her research focuses on investigating the molecular mechanisms underlying neonatal brain injury to better inform treatment and understanding of long-term sequelae. Specifically, her work examines prenatal opioid exposure under the mentorship of Dr. Lauren Jantzie in the hopes of identifying biomarkers to guide treatment and long-term follow-up.